Skip To Main Content
Mie Dyberg Skandov on Muck Rack

Mie Dyberg Skandov

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Mie Dyberg

Contact Mie Dyberg, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Real-World Use of Semaglutide for Weight Management: Dose Titration, Discontinuation Patterns and Weight Changes

|
By Katrine Christensen, Dagmar Abelone Dalin, Mie Dyberg Skandov
| Wiley Online Library Verified
1 Introduction Glucagon-like peptide-1 receptor agonists (GLP-1RA) have emerged over the past years as a huge breakthrough in the pharmacological treatment of overweight and obesity. In December 2022, semaglutide, a GLP-1RA, was introduced in Denmark as an injectable treatment for weight management as an adjunct to lifestyle modifications.
Open in Who Shared Issue with article?
See all 1 articles